CVM
CEL-SCI Corporation · AMEX:CVM
1.31 USD−0.0700 −5.07%
CEL-SCI Corporation (AMEX:CVM) last traded at 1.31 USD, down 5.07% on the day. Over the past year the stock is down 80.96%. Its 52-week range is 0.8900 to 7.80. It is in the Health Technology sector (Biotechnology).
Key statistics
Open1.39
Day range1.30 – 1.44
52-week range0.8900 – 7.80
Volume91.94 K
Average volume (10 days)109.53 K
Market cap23.04 M
EPS (TTM)−2.58
Dividend yield0.00%
Beta (1 year)3.47
Revenue (TTM)0
Performance
−23.39%1 week
−38.79%1 month
+4.80%3 months
−25.14%6 months
−75.38%Year to date
−80.96%1 year
Technical reading
Bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year SurvivalBusinessWire · 26 Oct 2026
- CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and LaryngologyBusinessWire · 15 Sep 2026
- Cancer immunotherapy developer CEL-SCI's Q3 net loss unchangedReuters · 17 Aug 2026
- CEL-SCI 3Q Loss/Shr 47c >CVMDow Jones Newswires · 17 Aug 2026
- CEL-SCI 3Q Research and Development Expenses $3.6M >CVMDow Jones Newswires · 17 Aug 2026
- BRIEF-CEL-SCI Corporation Q2 EPS USD -0.47Reuters · 17 Aug 2026
- CEL-SCI Reports Fiscal Third Quarter 2026 ResultsBusinessWire · 17 Aug 2026
- CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration StudyBusinessWire · 04 Aug 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.